118 related articles for article (PubMed ID: 8327566)
21. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
23. Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of 14C-tiropramide to the rat.
Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
Arzneimittelforschung; 1988 Dec; 38(12):1815-9. PubMed ID: 3245854
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
28. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
30. [The pharmacokinetics and metabolism of bonnecor in rats].
Klemm V; Morgenroth U; Starke F; Zeriatke W; Ioram U
Farmakol Toksikol; 1990; 53(3):43-4. PubMed ID: 2387379
[TBL] [Abstract][Full Text] [Related]
31. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs.
Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L
Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
Shayeganpour A; Hamdy DA; Brocks DR
Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of deramciclane in rabbits.
Lengyel J; Bojti E; Bolehovszky A; Grézal G; Klebovich I; Magyar K
Arzneimittelforschung; 1998 Nov; 48(11):1063-8. PubMed ID: 9850425
[TBL] [Abstract][Full Text] [Related]
34. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
Gaete LE; Ortiz M; Soto J; Saavedra I
Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
[TBL] [Abstract][Full Text] [Related]
35. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
Fromm MF; Darbar D; Dell'Orto S; Roden DM
J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
[TBL] [Abstract][Full Text] [Related]
36. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
37. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
38. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
39. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
40. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]